Overview
Conference: October 24-25, 2024
In a market that is constantly adapting and adjusting to the needs of the healthcare field, real-world evidence (RWE) is becoming increasingly important for regulatory and reimbursement decision-making. Historically used for post-market safety monitoring, RWE is now integrated throughout the product development lifecycle, and has led to the real-time analysis of data to better understand and gain insights on disease, approaches to treatment, and how to substantiate coverage decisions.
DIA’s Real-World Evidence Conference will explore new, innovative applications of RWE, and deliver cutting-edge insights to leverage this knowledge to advance healthcare decision-making.
Located in the Sweet Spot of PA
Hosting our 2024 conference, the Sheraton Philadelphia Downtown offers a home away from home. During your stay, enjoy the 24-hour fitness center, easy access to local cuisine, historic landmarks and museums, and 30th Street Station just five minutes away.
Need Approval in Order to Attend?
Download and fill out our Justification Letter to demand to supervisor why this is a must-attend event.
Participant Testimonials
DIA RWE is the best RWE-related event I've attended - it has compelling speakers, strong education opportunities, and a great collective of attendees. – Nicholaas Honig, JD, Senior Regulatory Counsel, Aetion
Great meeting. Very strong content. Was a really efficient way for me to catch up on RWD/E happenings over the past year! – Meredith Zozus, PhD, Professor; Division Chief and Director, Clinical Research Informatics, University of Texas Health Science Center
Program Committee
-
David Martin, MD, MPH Vice President, Global Head RWE
Moderna, United States -
Jaclyn Bosco, PhD, MPH, FISPE Vice President and Global Head of Epidemiology
IQVIA, United States -
John Concato, MD, MPH, MS Associate Director for Real-World Evidence Analytics, OMP, CDER
FDA, United States -
Diane Gubernot, DrPH, MPH Epidemiologist
US FDA, United States -
Rachele Hendricks-Sturrup, DrSc, MA, MSc Research Director, Real-World Evidence
Duke-Robert J. Margolis, MD, Center for Health Policy, United States -
Camille Jackson Director, Regulatory Policy; Legal and Regulatory
Flatiron Health , United States -
Charles Lee, MBA, MS Executive Regulatory Science Director
AstraZeneca, United States -
Alexander Liede, PhD, MSc Senior Director, Global Epidemiology
Abbvie, Ireland -
Sarah Martin, PhD, MS Senior Director - Global Regulatory Policy (Oncology)
Eli Lilly & Co., United States -
Brittany McKelvey, PhD Director, Regualtory Affairs
Friends of Cancer Research, United States -
Keri Monda, PhD, MS Executive Director, Center for Observational Research
Amgen, United States -
Representative Invited DIA, United States -
Representative Invited DIA, United States
Have an account?